The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future - Université de Lorraine Access content directly
Journal Articles The American Journal of Medicine Year : 2020

The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future

Abstract

The current Coronavirus Disease 2019 (COVID-19) pandemic has exerted an unprecedented impact across the globe. As a consequence of this overwhelming catastrophe, long-established prevailing medical and scientific paradigms have been disrupted. The response of the scientific community, medical journals, media, and some politicians has been far from ideal. The present manuscript discusses the failure of the scientific enterprise in its initiatives to address the COVID-19 outbreak as a consequence of the disarray attributable to haste and urgency. To enhance conveying our message, this manuscript is organized into 3 interrelated sections: 1) the accelerated pace of publications coupled with a dysfunctional review process; 2) failure of the clinical trial enterprise; 3) propagation of misleading information by the media. In response we propose a template comprising a focus on randomized controlled clinical trials, and an insistence on responsible journal publication, and enumeration of policies to deal with social media-propagated news. We conclude with a reconsideration of the appropriate role of academic medicine and journals.
Fichier principal
Vignette du fichier
The Decline of the Experimental Paradigm During the COVID-19 Pandemic A Template for the Future.pdf (717.53 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-03007932 , version 1 (19-11-2020)

Identifiers

Cite

João Pedro Ferreira, Murray Epstein, Faiez Zannad. The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future. The American Journal of Medicine, 2020, S0002-9343 (20), pp.30794-4. ⟨10.1016/j.amjmed.2020.08.021⟩. ⟨hal-03007932⟩
25 View
42 Download

Altmetric

Share

Gmail Facebook X LinkedIn More